IGI Inc. of Buena, N.J., announced that a new lipid vesiclepatent, U.S. Patent No. 5,213,805, has been issued to one of itssubsidiaries, MVS.
The patent provides a choice of building materials forNovasome drug encapsulations using safe, inexpensivederivatives of soy and tall bean oils that are already used asdiluents in industry and agriculture for such products as paintsand biocides. Their utility for foods, biologicals andpharmaceuticals has not yet been established.
A total of 22 U.S. and 25 foreign patents covering MVS'sNovasome and Ultrasponge technologies have been issued. Anadditional 75 patents are pending.
(c) 1997 American Health Consultants. All rights reserved.